Feb 24 2009, 8:40 AM EST
PRNEWSWIRE
Accellerase(R) 1500 is another significant step toward commercialization of biofuels and other biochemicals made from cellulosic feedstocks, such as agricultural residues and bioenergy crops. It also reinforces Genencor's position as a global leader in 2nd generation ethanol innovation.
"We're on course to fast-track commercialization of cellulosic ethanol," says
Accellerase(R) 1500 will lower one of the major cost hurdles to producing ethanol or biochemicals from cellulosic feedstocks, such as corn stover, sugarcane bagasse, wood chips, wheat straw, and switchgrass. In addition, Accellerase(R) 1500 has a significantly improved formulation and higher activity resulting in higher ethanol yields and robust operation in a wider variety of processes. The product is based on Genencor's patented gene expression technology and the division's 25-year history of biofuels research.
Accellerase(R) is critical to the hydrolysis step of converting biomass to ethanol or other biochemicals. In this step, plant material is broken down into sugars for fermentation to ethanol.
Genencor supplies Accellerase(R) as part of its dual-strategy to drive forward the cellulosic ethanol industry, which includes its dedicated enzyme business, and its joint venture DuPont Danisco Cellulosic Ethanol LLC (DDCE), which develops and provides integrated technology packages for biomass ethanol production.
Genencor, a division of Danisco A/S, is a world leader in industrial biotechnology and a pioneer in enzyme innovation. Genencor improves process and product performance for a spectrum of industries, from biofuels and laundry detergents to animal nutrition and food. As part of a large global organization, Genencor has a manufacturing and distribution network that spans more than 40 countries. In collaboration with customers, technology leaders and other stakeholders, Genencor supplies competitive, biobased solutions. These innovations create value throughout the supply chain, from raw material to finished product.
SOURCE Genencor
INTERVIEW:
(BIO) BANKING IN LUXEMBOURG - Interview with Robert Hewitt, Ph.D., CEO, Integrated Biobank of Luxembourg, and European Editor, Biopreservation and Biobanking (published by Mary Ann Liebert, Inc.)
...MORE
News
Articles
Blogs| Most Viewed | Most Emailed | Top Searches |
|---|---|---|
| Unclog the Innovation Bottleneck at our Nation’s Universities | ||
| (Bio) Banking in Luxembourg | ||